SIMPLIMAX Trademark

Trademark Overview


On Thursday, April 15, 2021, a trademark application was filed for SIMPLIMAX with the United States Patent and Trademark Office. The USPTO has given the SIMPLIMAX trademark a serial number of 90648763. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, November 14, 2024. This trademark is owned by Xtant Medical Holdings, Inc.. The SIMPLIMAX trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue

General Information


Serial Number90648763
Word MarkSIMPLIMAX
Filing DateThursday, April 15, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements


Goods and ServicesHuman allograft tissue
Pseudo MarkSIMPLY MAX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 23, 2021
Primary Code005
First Use Anywhere DateFriday, March 29, 2024
First Use In Commerce DateFriday, March 29, 2024

Trademark Owner History


Party NameXtant Medical Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBelgrade, MT 59714

Party NameXtant Medical Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelgrade, MT 59714

Trademark Events


Event DateEvent Description
Monday, April 19, 2021NEW APPLICATION ENTERED
Friday, July 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 22, 2021ASSIGNED TO EXAMINER
Wednesday, September 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022SOU EXTENSION 1 FILED
Tuesday, May 24, 2022SOU EXTENSION 1 GRANTED
Thursday, May 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2022SOU EXTENSION 2 FILED
Friday, December 16, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 3 FILED
Tuesday, June 13, 2023SOU EXTENSION 3 GRANTED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 15, 2023SOU EXTENSION 4 FILED
Wednesday, November 15, 2023SOU EXTENSION 4 GRANTED
Friday, November 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 31, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2024SOU EXTENSION 5 GRANTED
Wednesday, June 19, 2024SOU EXTENSION 5 FILED
Friday, September 13, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, November 6, 2024USE AMENDMENT FILED
Wednesday, November 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 6, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords


simplimax tissue allograft human